Abstract: A mobile solar power unit control system providing power to an associated equipment item comprising: at least one mobile solar power unit comprising an assembly of inter-connected solar collector panels; an energy storage module connected to receive power from the assembly of inter-connected solar panels; and a control system for controlling operation of both the energy storage module and associated equipment item. The control system comprises a local controller onboard or proximate the at least one mobile solar power unit and a remote controller, communicable with the local controller, located remotely from said at least one mobile solar power unit. The mobile solar power unit conveniently provides power for an associated equipment item and any selected auxiliary loads located in an off-grid location.

Abstract: A mobile solar panel unit (10) comprising: (a) a transport device (10) having a load zone (20) having a cross sectional area; and (b) an assembly (30) of a plurality of inter-connected solar collector panels (40, 42, 44) for providing, in use, power to an associated equipment item (70); wherein adjacent panels (40, 42; 42, 44) in said assembly (30) of solar collector panels (40, 42, 44) are inter-connected by rotatable connection means (50, 50a) for rotating panels (40, 44) allowing both storage of said assembly (30) of inter-connected solar collector panels (40, 42; 42, 44) in said load zone (20) and deployment of said assembly (30) of inter-connected solar collector panels (40, 42, 44) to a collection position to generate power when exposed to sunlight.

Abstract: Methods of accelerating or improving the healing of a skin graft or skin grafting site in a subject are provided comprising administering to the subject an amount of an inhibitor of fidgetin-like 2.

Abstract: Methods and compositions for reducing a ratio of collagen III to collagen I in wounded skin, treating wounds and accelerating healing is provided with a surfactant polymer dressing comprising FL2 siRNA, collagen and a poloxamer.

Abstract: Methods are described for enhancing the tumor homing or penetration activity of T-cells to improve cancer treatment, by exposing T-cells in vitro, ex vivo or in vivo to an agent that inhibits fidgetin-like 2 activity, such as by using an RNA interference agent.